Bovine TB vaccine Consultant
Estimated value
£22k
Awarded value
£22k
Suppliers
1
Lots
1
Published
20 Jan 2025
Description
To provide ongoing regulatory consultancy for the CattleBCG vaccine programme . Movement into this final and critical phase of the project makes it imperative that continuity of advice is with someone well-versed with the work undertaken to-date. This contract will provide regulatory support to the TB cattle vaccine field trial project and ongoing regulatory oversight to construction of the Market Authorisation (MA) Dossier submissions to VMD for the licenced use of BCG and the companion DIVA test in the UK. Providing specialised and technical advice on the requirements for: • Negotiations with commercial GMP providers • Providing specialised and technical advice on the design and execution of vaccine research and development • Licensing of a vaccine for cattle with associated DIVA diagnostic test for use in the Cattle Tuberculosis Eradication Strategy throughout UK licensing of vaccines; and • The regulation and commercialisation of cattle vaccine and related in-vivo and in-vitro diagnostic assays.
Scope
- Reference
- CF-0442300D8d000003VQwdEAG
- Total value
- £22,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Jan 2025 to 30 Mar 2025
- CPV classifications
- 71600000
Submission & procedure
- Submission deadline
- 02 Dec 2024, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£22k
Award date
14 Jan 2025
Contract start
01 Jan 2025
Contract end
30 Mar 2025
Awarded suppliers· 1 supplier
Awarded 14 Jan 2025 · Contract period 01 Jan 2025 — 30 Mar 2025
Other contracts from ANIMAL AND PLANT HEALTH AGENCY
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Veterinary Vaccines Consultancy Ltd· 2
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Bovine TB vaccine Consultant | contract | £50k | 09 Oct 2023 |
| Specialist Advice (Regulatory and Commercial) on the Development of TB Vaccines | call off | £18k | 28 Mar 2017 |